{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Tilarginine",
  "nciThesaurus": {
    "casRegistry": "17035-90-4",
    "chebiId": "CHEBI:28229",
    "chemicalFormula": "C7H16N4O2",
    "definition": "A pan-nitric oxide synthase (NOS) inhibitor, with potential immunomodulating and antineoplastic activities. Upon administration, tilarginine binds to and inhibits NOS, a free radical signaling molecule that promotes angiogenesis, metastasis, and immunosuppression in the tumor microenvironment (TME). Reduction in NOS activity may abrogate the immunosuppressive TME, enhance tumor antigen-specific immune response and inhibit tumor cell proliferation.",
    "fdaUniiCode": "27JT06E6GR",
    "identifier": "C1178",
    "preferredName": "Tilarginine",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [],
    "synonyms": [
      "L-NMMA",
      "Monomethylarginine",
      "N-Methylarginine",
      "N5-(Methylamidino)-L-ornithine",
      "NG-Monomethyl-L-Arginine",
      "NG-monomethyl-L-arginine",
      "NMA",
      "TILARGININE",
      "Targinine",
      "Tilarginine",
      "omega-N-Monomethylarginine"
    ]
  }
}